FIELD: medicine. SUBSTANCE: method involves administering one of preparations of furocoumarin line in generally accepted dose 2 h before applying laser coagulation treatment. EFFECT: reduced power of argon laser radiation; reduced heat action upon retina and choroids; reduced risk of complications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING NEOVASCULAR DIABETIC RETINOPATHY | 1992 |
|
RU2057503C1 |
| METHOD FOR PHOTODYNAMIC THERAPY OF PROLIFERATIVE DIABETIC RETINOPATHY | 2010 |
|
RU2447870C1 |
| METHOD OF TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY | 0 |
|
SU1500288A1 |
| METHOD FOR TREATING PATIENTS FOR PRE- AND PROLIFERATIVE RETINOPATHY | 2005 |
|
RU2283647C1 |
| METHOD OF LASER RETINAL COAGULATION IN PROLIFERATIVE DIABETIC RETINOPATHY | 2017 |
|
RU2666269C1 |
| METHOD FOR GRADUAL STEPWISE LASER TREATMENT OF RETINOSCHISIS | 2010 |
|
RU2441631C2 |
| METHOD FOR PREVENTING RETINAL EDEMA AND TRACTION IN MACULAR ZONE WHEN APPLYING TRANSPUPILLARY DIODE LASER THERAPY TO PARACENTRAL CHOROID TUMORS | 2003 |
|
RU2238068C1 |
| METHOD FOR REMOVING FOLDS IN RETINA NOT COVERING FOVEAL AREA | 1989 |
|
RU2057499C1 |
| METHOD FOR TREATING SUBRETINAL NEOVASCULAR MEMBRANE | 1998 |
|
RU2179007C2 |
| METHOD OF PREVENTING NEOVASCULAR GLAUCOMA | 0 |
|
SU1621922A1 |
